Two sets of results from a large U.S. government-sponsored trial find that neither aggressive treatment of cholesterol nor of blood pressure lowers the risk of heart events in people with type 2 diabetes.
"These results could be disappointing to a lot of people -- that this intensive blood pressure control or intensive lipid control didn't reduce fatal or nonfatal events," said Dr. Stephen Kopecky, a cardiologist and professor of medicine at the Mayo Clinic in Rochester, Minn.
HealthDay, by Amanda Gardner, 3/14/2010
Additional coverage:
Tags: Cardiology, cholesterol, diabetes, Dr. Stephen Kopecky, Endocrinology / Diabetes, lipid control